These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 25286960)
1. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. Zhang B; Xing X; Li J; Lowdon RF; Zhou Y; Lin N; Zhang B; Sundaram V; Chiappinelli KB; Hagemann IS; Mutch DG; Goodfellow PJ; Wang T BMC Genomics; 2014 Oct; 15(1):868. PubMed ID: 25286960 [TBL] [Abstract][Full Text] [Related]
2. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670 [TBL] [Abstract][Full Text] [Related]
3. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines. Sánchez-Vega F; Gotea V; Petrykowska HM; Margolin G; Krivak TC; DeLoia JA; Bell DW; Elnitski L Epigenetics; 2013 Dec; 8(12):1355-72. PubMed ID: 24149212 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer. Wang Y; Liu D; Jin X; Song H; Lou G Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607 [TBL] [Abstract][Full Text] [Related]
5. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372 [TBL] [Abstract][Full Text] [Related]
6. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas. Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731 [TBL] [Abstract][Full Text] [Related]
7. Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and autonomic neuropathy 1E. Sun Z; Wu Y; Ordog T; Baheti S; Nie J; Duan X; Hojo K; Kocher JP; Dyck PJ; Klein CJ Epigenetics; 2014 Aug; 9(8):1184-93. PubMed ID: 25033457 [TBL] [Abstract][Full Text] [Related]
8. Identification of endometrial cancer methylation features using combined methylation analysis methods. Trimarchi MP; Yan P; Groden J; Bundschuh R; Goodfellow PJ PLoS One; 2017; 12(3):e0173242. PubMed ID: 28278225 [TBL] [Abstract][Full Text] [Related]
9. Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair. Helmle KE; Otto CJ; Constantinescu G; Honore LH; Andrew SE Int J Gynecol Cancer; 2005; 15(6):1089-96. PubMed ID: 16343186 [TBL] [Abstract][Full Text] [Related]
10. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062 [TBL] [Abstract][Full Text] [Related]
11. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications. Xiong Y; Dowdy SC; Eberhardt NL; Podratz KC; Jiang SW Gynecol Oncol; 2006 Oct; 103(1):321-8. PubMed ID: 16701802 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic signatures of familial cancer are characteristic of tumor type and family category. Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504 [TBL] [Abstract][Full Text] [Related]
13. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma. Li J; Xing X; Li D; Zhang B; Mutch DG; Hagemann IS; Wang T Neoplasia; 2017 Feb; 19(2):100-111. PubMed ID: 28088687 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide high-resolution mapping of DNA methylation identifies epigenetic variation across embryo and endosperm in Maize (Zea may). Wang P; Xia H; Zhang Y; Zhao S; Zhao C; Hou L; Li C; Li A; Ma C; Wang X BMC Genomics; 2015 Jan; 16(1):21. PubMed ID: 25612809 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens. Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769 [TBL] [Abstract][Full Text] [Related]
16. Integrated epigenomic analyses of enhancer as well as promoter regions in gastric cancer. Baek SJ; Kim M; Bae DH; Kim JH; Kim HJ; Han ME; Oh SO; Kim YS; Kim SY Oncotarget; 2016 May; 7(18):25620-31. PubMed ID: 27016420 [TBL] [Abstract][Full Text] [Related]
17. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers. Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987 [TBL] [Abstract][Full Text] [Related]